
BCL6-IN-6
CAS No. 2408882-54-0
BCL6-IN-6( —— )
Catalog No. M28485 CAS No. 2408882-54-0
BCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 152 | Get Quote |
![]() ![]() |
5MG | 260 | Get Quote |
![]() ![]() |
10MG | 447 | Get Quote |
![]() ![]() |
25MG | 714 | Get Quote |
![]() ![]() |
50MG | 1017 | Get Quote |
![]() ![]() |
100MG | 1368 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBCL6-IN-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.
-
DescriptionBCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorSARS-CoV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2408882-54-0
-
Formula Weight522.64
-
Molecular FormulaC27H31FN6O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 4 mg/mL (7.65 mM)
-
SMILESN(C1=NC(=NC=C1F)N2C[C@H](C)N[C@H](C)C2)C3=CC(OC)=C(NC(=O)C=4SC(=CC4)C=5CCCC5)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Paederosidic acid
Paederosidic acid has significant anti-tumor anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain and it up-regulates expressions of GAD 65 may be a promising future therapeutic agent for treatment of epilepsy.
-
AZD 4320
AZD4320 is a BH3 mimetic and dual Bcl-2/Bcl-XL inhibitor with IC50 of <1 nM.
-
Gossypol
Gossypol (BL-193) is a natural phenol that permeates cells and acts as an inhibitor for several dehydrogenase enzymes such as lactate dehydrogenase, NAD-linked enzymes.